Sergio Santillana
Fondatore presso Slss Consulting LLC
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Sergio Santillana
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Slss Consulting LLC | Fondatore | - | - |
| Presidente | - | - |
Storia della carriera di Sergio Santillana
Precedenti posizioni note di Sergio Santillana
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IKENA ONCOLOGY, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2020 | 29/02/2024 |
| MERRIMACK PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 12/06/2017 | 12/04/2019 |
| ARIAD PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2016 | 01/06/2017 |
| Corporate Officer/Principal | 01/03/2016 | 01/05/2016 | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Corporate Officer/Principal | 01/08/2014 | 01/03/2016 |
| GSK PLC | Corporate Officer/Principal | 01/02/2012 | 01/08/2014 |
Formazione di Sergio Santillana
| Kellogg College | Graduate Degree |
| Universidad Nacional Federico Villarreal | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 3 |
| Perù | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Graduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GSK PLC | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Commercial Services |
| Slss Consulting LLC |
- Borsa valori
- Insiders
- Sergio Santillana
- Esperienza
